A detailed history of Franklin Resources Inc transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Franklin Resources Inc holds 27,005 shares of COLL stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,005
Previous 25,007 7.99%
Holding current value
$1.05 Million
Previous $970,000 10.41%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$31.36 - $39.99 $62,657 - $79,900
1,998 Added 7.99%
27,005 $869,000
Q1 2024

May 13, 2024

BUY
$31.23 - $40.91 $19,643 - $25,732
629 Added 2.58%
25,007 $970,000
Q4 2023

Feb 09, 2024

BUY
$21.16 - $30.8 $33,369 - $48,571
1,577 Added 6.92%
24,378 $750,000
Q3 2023

Nov 13, 2023

BUY
$21.23 - $24.28 $92,499 - $105,787
4,357 Added 23.62%
22,801 $509,000
Q2 2023

Aug 11, 2023

BUY
$21.06 - $24.0 $388,430 - $442,656
18,444 New
18,444 $396,000
Q1 2021

May 13, 2021

SELL
$19.25 - $26.1 $24.2 Million - $32.8 Million
-1,255,371 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$17.83 - $22.29 $7.32 Million - $9.15 Million
-410,501 Reduced 24.64%
1,255,371 $25.1 Million
Q3 2020

Nov 12, 2020

BUY
$15.78 - $20.82 $19,078 - $25,171
1,209 Added 0.07%
1,665,872 $34.7 Million
Q2 2020

Aug 13, 2020

SELL
$15.49 - $23.51 $2.56 Million - $3.88 Million
-165,109 Reduced 9.02%
1,664,663 $29.1 Million
Q1 2020

May 13, 2020

BUY
$13.89 - $25.45 $828,121 - $1.52 Million
59,620 Added 3.37%
1,829,772 $29.9 Million
Q4 2019

Feb 12, 2020

SELL
$10.7 - $22.24 $993,163 - $2.06 Million
-92,819 Reduced 4.98%
1,770,152 $36.4 Million
Q3 2019

Nov 14, 2019

BUY
$10.16 - $13.28 $72,400 - $94,633
7,126 Added 0.38%
1,862,971 $21.4 Million
Q2 2019

Aug 14, 2019

BUY
$10.62 - $16.59 $233,714 - $365,096
22,007 Added 1.2%
1,855,845 $24.4 Million
Q1 2019

May 14, 2019

SELL
$13.58 - $18.72 $6,124 - $8,442
-451 Reduced 0.02%
1,833,838 $27.8 Million
Q4 2018

Feb 12, 2019

BUY
$14.78 - $19.68 $1.11 Million - $1.47 Million
74,783 Added 4.25%
1,834,289 $31.5 Million
Q3 2018

Nov 13, 2018

BUY
$14.16 - $24.3 $4.91 Million - $8.43 Million
347,064 Added 24.57%
1,759,506 $25.9 Million
Q2 2018

Aug 14, 2018

SELL
$21.79 - $28.29 $1.23 Million - $1.6 Million
-56,677 Reduced 3.86%
1,412,442 $33.7 Million
Q1 2018

May 10, 2018

SELL
$18.15 - $29.21 $774,206 - $1.25 Million
-42,656 Reduced 2.82%
1,469,119 $37.5 Million
Q4 2017

Feb 14, 2018

SELL
$9.3 - $19.14 $6.71 Million - $13.8 Million
-721,372 Reduced 32.3%
1,511,775 $27.9 Million
Q3 2017

Nov 13, 2017

BUY
$9.15 - $11.97 $20.4 Million - $26.7 Million
2,233,147
2,233,147 $23.4 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $1.32B
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.